Shingles Research Today is a free monthly online journal that collates and summarizes the latest research about Shingles, including details on symptoms, treatment, causes, virus.

Volume 4 (2008), Issue 2 (February)

1. A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax.
   Clin Vaccine Immunol, 15(2): 314-9. [Abstract] [Full-text]
2. Preventing herpes zoster through vaccination.
   Ophthalmology, 115(2): S35-8. [Abstract] [Full-text]
3. Use of photorefractive keratectomy in a patient with a corneal scar secondary to herpes zoster ophthalmicus.
   Ophthalmology, 115(2): S33-4. [Abstract] [Full-text]
4. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
   Ophthalmology, 115(2): S3-12. [Abstract] [Full-text]
5. Anterior segment complications of herpes zoster ophthalmicus.
   Ophthalmology, 115(2): S24-32. [Abstract] [Full-text]
6. Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy.
   Ophthalmology, 115(2): S21-3. [Abstract] [Full-text]
7. Herpes zoster antivirals and pain management.
   Ophthalmology, 115(2): S13-20. [Abstract] [Full-text]
8. Ophthalmologic complications of systemic disease.
   Emerg Med Clin North Am, 26(1): 217-31. [Abstract] [Full-text]
9. Corticosteroids for preventing postherpetic neuralgia.
   Cochrane Database Syst Rev. [Abstract] [Full-text]
10. Lidocaine plasters for postherpetic neuralgia?
    Drug Ther Bull, 46(2): 14-6. [Abstract] [Full-text]
11. A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies.
    Blood, 111(4): 1848-54. [Abstract] [Full-text]
12. Varicella-Zoster Virus in the Saliva of Patients with Herpes Zoster.
    J Infect Dis. [Abstract] [Full-text]
13. Transmission of a Newly Characterized Strain of Varicella-Zoster Virus from a Patient with Herpes Zoster in a Long-Term-Care Facility, West Virginia, 2004.
    J Infect Dis. [Abstract] [Full-text]
14. New viral vaccines for dermatologic disease.
    J Am Acad Dermatol, 58(3): 361-70. [Abstract] [Full-text]
15. A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system.
    J Virol Methods, 148(1): 197-204. [Abstract] [Full-text]

© 2005-2008 Shingles Research Today. All Rights Reserved.